CGEM Operating Cash Flow Growth

Cullinan Therapeutics Inc · Operating Cash Flow Growth

CGEM logo

CGEM Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported7.16%
CGEM TTM Cash from Operations YoY % (-42.47% → 7.16%)
High-resolution chart · PNG

CGEM operating cash flow growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Cullinan Therapeutics Inc Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
7.1586%
-18.926%
-20.9541%
-37.4259%
-35.2646%
-23.605%
-8.213%
10.1462%
21.4015%
21.9758%
-6.0088%
-20.7741%
-120.8611%
-144.0275%
-191.6308%
-209.9687%
-101.6953%
-142.9431%
-45.8854%
-49.5656%
-64.6198%
-26.1167%
-42.4702%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.